Literature DB >> 24144674

Comparative analysis of the neurovascular injury and functional outcomes in experimental stroke models in diabetic Goto-Kakizaki rats.

Weiguo Li1, Zhi Qu, Roshini Prakash, Connie Chung, Handong Ma, Md Nasrul Hoda, Susan C Fagan, Adviye Ergul.   

Abstract

Diabetes worsens functional outcome and is associated with greater hemorrhagic transformation (HT) after ischemic stroke. We have shown that diabetic Goto-Kakizaki (GK) rats develop greater HT and neurological deficit despite smaller infarcts after transient middle cerebral artery occlusion (MCAO) with the suture model. However, the impact of (1) the duration of ischemia/reperfusion (I/R); (2) the method of ischemia; and (3) acute glycemic control on neurovascular injury and functional outcome in diabetic stroke remained unanswered. Wistar and GK rats were subjected to variable MCAO by suture or embolus occlusion. A group of GK rats were treated with insulin or metformin before stroke with suture occlusion. In all groups, infarct size, edema, HT occurrence and severity, and functional outcome were measured. Infarct size at 24h was smaller in GK rats with both suture and embolic MCAO, but expanded with longer reperfusion period. Edema and HT were increased in GK rats after 90min and 3h occlusion with the suture model, but not in the embolic MCAO. Neurological deficit was greater in diabetic rats. These findings suggest that diabetes accelerates the development of HT and amplifies vascular damage in the suture model where blood flow is rapidly reestablished. Acute metformin treatment worsened the infarct size, HT, and behavior outcome, whereas insulin treatment showed a protective effect. These results suggest that the impact of ischemia/reperfusion on neurovascular injury and functional outcome especially in disease models needs to be fully characterized using different models of stroke to model the human condition.
© 2013 Published by Elsevier B.V.

Entities:  

Keywords:  2,3,5-triphenyltetrazolium chloride; AMP; AMP-activated protein kinase; AMPK; ANOVA; Adenosine monophosphate; Analysis of variance; BBB; Blood-brain barrier; Diabetes; ECA; Edema; External carotid artery; GK; Goto-Kakizaki; HT; Hemorrhagic transformation; I/R; Infarct; Ischemia/reperfusion; Ischemic stroke; MCAO; Metformin; Middle cerebral artery occlusion; NBG; Normal blood glucose; PE; Polyethylene; SEM; STAIR; Standard error of the mean; Stroke Therapy Academia Industry Roundtable committee; TTC; Tissue plasminogen activator; met; tPA

Mesh:

Year:  2013        PMID: 24144674      PMCID: PMC3878856          DOI: 10.1016/j.brainres.2013.10.021

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  48 in total

1.  Hemorrhagic transformation in focal cerebral ischemia: influence of time to artery reopening and tissue plasminogen activator.

Authors:  S C Fagan; J H Garcia
Journal:  Pharmacotherapy       Date:  1999-02       Impact factor: 4.705

2.  Cerebral ischemia-induced apoptosis and necrosis in normal and diabetic rats: effects of insulin and C-peptide.

Authors:  Natalie N Rizk; José A Rafols; Joseph C Dunbar
Journal:  Brain Res       Date:  2006-05-24       Impact factor: 3.252

3.  Influence of hyperglycemia on oxidative stress and matrix metalloproteinase-9 activation after focal cerebral ischemia/reperfusion in rats: relation to blood-brain barrier dysfunction.

Authors:  Hiroshi Kamada; Fengshan Yu; Chikako Nito; Pak H Chan
Journal:  Stroke       Date:  2007-02-01       Impact factor: 7.914

4.  Functional recovery after ischemic stroke--a matter of age: data from the Austrian Stroke Unit Registry.

Authors:  M Knoflach; B Matosevic; M Rücker; M Furtner; A Mair; G Wille; A Zangerle; P Werner; J Ferrari; C Schmidauer; L Seyfang; S Kiechl; J Willeit
Journal:  Neurology       Date:  2012-01-11       Impact factor: 9.910

5.  Hyperbaric oxygen-induced attenuation of hemorrhagic transformation after experimental focal transient cerebral ischemia.

Authors:  Zhiyong Qin; Murat Karabiyikoglu; Ya Hua; Robert Silbergleit; Yangdong He; Richard F Keep; Guohua Xi
Journal:  Stroke       Date:  2007-02-22       Impact factor: 7.914

Review 6.  Hemorrhagic transformation following ischemic stroke: significance, causes, and relationship to therapy and treatment.

Authors:  Paul A Lapchak
Journal:  Curr Neurol Neurosci Rep       Date:  2002-01       Impact factor: 5.081

Review 7.  Implications of new diabetes treatment trials: should current clinical practice be altered?

Authors:  Jeffrey D Kravetz; Daniel G Federman
Journal:  Postgrad Med       Date:  2009-05       Impact factor: 3.840

8.  Insulin-induced activation of glycerol-3-phosphate acyltransferase by a chiro-inositol-containing insulin mediator is defective in adipocytes of insulin-resistant, type II diabetic, Goto-Kakizaki rats.

Authors:  R V Farese; M L Standaert; K Yamada; L C Huang; C Zhang; D R Cooper; Z Wang; Y Yang; S Suzuki; T Toyota
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

9.  Diabetes as a risk factor for stroke. A population perspective.

Authors:  B Stegmayr; K Asplund
Journal:  Diabetologia       Date:  1995-09       Impact factor: 10.122

10.  Admission hyperglycemia predicts a worse outcome in stroke patients treated with intravenous thrombolysis.

Authors:  Alexandre Y Poppe; Sumit R Majumdar; Thomas Jeerakathil; William Ghali; Alastair M Buchan; Michael D Hill
Journal:  Diabetes Care       Date:  2009-01-08       Impact factor: 17.152

View more
  27 in total

1.  Effect of TTC Treatment on Immunohistochemical Quantification of Collagen IV in Rat Brains after Stroke.

Authors:  Zhaojin Li; Nicole Bishop; Siu-Lung Chan; Marilyn J Cipolla
Journal:  Transl Stroke Res       Date:  2018-01-08       Impact factor: 6.829

2.  Linagliptin treatment improves cerebrovascular function and remodeling and restores reduced cerebral perfusion in Type 2 diabetes.

Authors:  Trevor Hardigan; Abdul Yasir; Mohammed Abdelsaid; Maha Coucha; Sally El-Shaffey; Weiguo Li; Maribeth H Johnson; Adviye Ergul
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-06-29       Impact factor: 3.619

3.  Pre-stroke Metformin Treatment is Neuroprotective Involving AMPK Reduction.

Authors:  Tian Deng; Yan-Rong Zheng; Wei-Wei Hou; Yang Yuan; Zhe Shen; Xiao-Li Wu; Ying Chen; Li-San Zhang; Wei-Wei Hu; Zhong Chen; Xiang-Nan Zhang
Journal:  Neurochem Res       Date:  2016-06-27       Impact factor: 3.996

4.  Comparative Analysis of Different Methods of Ischemia/Reperfusion in Hyperglycemic Stroke Outcomes: Interaction with tPA.

Authors:  Sherif Hafez; Md Nasrul Hoda; Xinyue Guo; Maribeth H Johnson; Susan C Fagan; Adviye Ergul
Journal:  Transl Stroke Res       Date:  2015-02-17       Impact factor: 6.829

Review 5.  Cellular connections, microenvironment and brain angiogenesis in diabetes: Lost communication signals in the post-stroke period.

Authors:  Adviye Ergul; John Paul Valenzuela; Abdelrahman Y Fouda; Susan C Fagan
Journal:  Brain Res       Date:  2015-03-03       Impact factor: 3.252

Review 6.  Diabetic aggravation of stroke and animal models.

Authors:  Ashish K Rehni; Allen Liu; Miguel A Perez-Pinzon; Kunjan R Dave
Journal:  Exp Neurol       Date:  2017-03-06       Impact factor: 5.330

7.  MAPK pathway mediates the anti-oxidative effect of chicoric acid against cerebral ischemia-reperfusion injury in vivo.

Authors:  Linwei Jia; Yonghan Chen; Yao-Hui Tian; Gang Zhang
Journal:  Exp Ther Med       Date:  2017-12-05       Impact factor: 2.447

8.  Diabetes Worsens Functional Outcomes in Young Female Rats: Comparison of Stroke Models, Tissue Plasminogen Activator Effects, and Sexes.

Authors:  Weiguo Li; Rebecca Ward; John Paul Valenzuela; Guangkuo Dong; Susan C Fagan; Adviye Ergul
Journal:  Transl Stroke Res       Date:  2017-03-01       Impact factor: 6.829

9.  Persistent cerebrovascular damage after stroke in type two diabetic rats measured by magnetic resonance imaging.

Authors:  Guangliang Ding; Tao Yan; Jieli Chen; Michael Chopp; Lian Li; Qingjiang Li; Chengcheng Cui; Ruizhuo Ning; Quan Jiang
Journal:  Stroke       Date:  2014-12-18       Impact factor: 7.914

10.  Activation of AMP-activated protein kinase by metformin protects against global cerebral ischemia in male rats: interference of AMPK/PGC-1α pathway.

Authors:  Ghorbangol Ashabi; Fariba Khodagholi; Leila Khalaj; Mahdi Goudarzvand; Masoumeh Nasiri
Journal:  Metab Brain Dis       Date:  2014-01-18       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.